Impact of abnormal metabolic-immunoinflammatory pathway on splenomegaly in patients with chronic schizophrenia and exploration of risk factors: case-control study - Poll - MDSpire

Impact of abnormal metabolic-immunoinflammatory pathway on splenomegaly in patients with chronic schizophrenia and exploration of risk factors: case-control study

  • By

  • Yang Shen

  • Di Wang

  • Zhiyong Li

  • April 2, 2026

  • 0 min

Share

Original Source(s)

Impact of abnormal metabolic-immunoinflammatory pathway on splenomegaly in patients with chronic schizophrenia and exploration of risk factors: case-control study

  • by Yang Shen, Di Wang, Zhiyong Li

  • April 2, 2026

Related Content

Artificial intelligence approaches for schizophrenia prediction and its biomarkers using medical imaging data

Assessing the Use of Wearable Mobile-Monitoring Devices Among Individuals With Serious Mental Illness: Qualitative Acceptability and Feasibility Study

Case Study: Distinguishing Catatonia-like Symptoms from Catatonia in a Schizophrenia Patient with Guillain–Barré Syndrome